Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.22%)
As of: Sep 3, 2026 · 3:37 PM EDT

Starling Oncology (STLN) Operating Leases (2022 - 2026)

Analysis

Starling Oncology (STLN) Operating Leases (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 90.73 Bn 89.71 Bn 15.19 Bn
2 Tenet Healthcare 22.05 Bn 19.88 Bn 4.45 Bn
3 Encompass Health 12.13 Bn 12.00 Bn 1.34 Bn
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn
5 Universal Health Services 10.12 Bn 9.98 Bn 3.29 Bn
6 Ensign 9.97 Bn 9.64 Bn 306.24 Mn
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn
8 Pacs 6.73 Bn 6.57 Bn 338.46 Mn
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn
10 Starling Oncology 613.55 Mn 572.46 Mn 27.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.61 Mn
Mar 31, 2026 26.25 Mn
Dec 31, 2025 19.13 Mn
Sep 30, 2025 27.36 Mn
Jun 30, 2025 28.13 Mn
Mar 31, 2025 28.41 Mn
Dec 31, 2024 23.22 Mn
Sep 30, 2024 31.41 Mn
Jun 30, 2024 31.06 Mn
Mar 31, 2024 31.45 Mn
Dec 31, 2023 26.49 Mn
Sep 30, 2023 32.09 Mn
Jun 30, 2023 32.65 Mn
Mar 31, 2023 27.89 Mn
Dec 31, 2022 22.06 Mn
Sep 30, 2022 26.99 Mn
Jun 30, 2022 19.10 Mn
Mar 31, 2022 18.69 Mn